Author

P. K. Santhekadur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. N. Srinivas· 2 shared D. P. Kumar· 2 shared D. S· 2 shared A. Prashant· 1 shared P. Vishwanath· 1 shared S. B. Chidambaram· 1 shared S. Satish· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. N. Srinivas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 26, 2023

AATF-mediated Liver Damage and Inflammation to Cancer: Therapeutic Intervention by Curcumin in Experimental MASH-HCC

A. N. Srinivas, D. S, S. B. Chidambaram…·D. P. Kumar

This study shows curcumin reduces AATF-mediated liver damage and inflammation in MASH-HCC by downregulating AATF through the KLF4-Sp1 pathway in a mouse model.

DOI 10.1101/2023.05.26.542402

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivNov 28, 2022

AATF Inhibition Exerts Antiangiogenic Effects AgainstHuman Hepatocellular Carcinoma

D. S, A. N. Srinivas, A. Prashant…·D. P. Kumar

This study shows that inhibiting AATF suppresses angiogenesis in human hepatocellular carcinoma by increasing PEDF, suggesting AATF as a potential therapeutic target.

DOI 10.3389/fonc.2023.1130380

humanproteomics

𝕏 PostBluesky